A critical breakthrough in cancer investigation is emerging with the use of nanobodies to restore dysfunctional p53. This vital cancer inhibitor protein is frequently disabled in several forms of malignancies, https://socialskates.com/story23426361/mini-antibodies-revive-the-p53-protein-new-potential-approach-for-tumor-management